© Oxford University Press, 2004.
Lecture Series |
Evidence-based Reconstruction of Kampo Medicine: Part I—Is Kampo CAM?
Toyama Medical and Pharmaceutical University, Japan
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
I would like to express my hearty congratulations at the launching of the new journal Evidence-based Complementary and Alternative Medicine (eCAM). I would also like to thank the Editors, Drs Tomio Tada, Edwin Cooper and Nobuo Yamaguchi, for inviting me to contribute a lecture series on the evidential basis of Kampo (Chinese herbal) medicine.
This series will run for several issues with the following main topics (in this issue the first three topics are mainly covered):
- Is Kampo CAM?
- The historical background of Kampo
- What characterizes Kampo?
- Herbal compositions of Kampo medicines
- Composition and analysis of Kampo medicines
- Sho (symptoms)
- Construction of evidence for Kampo, based on Sho
- Various designs for clinical trials to construct an evidential basis for Kampo
- Outline of the existing evidence of using Kampo for the treatment of various diseases
Preliminary notes for those who are not acquainted with Kampo: the term ‘Kampo’ is
|
1. My Personal Path Towards the Integration of Two Medical Systems |
|---|
|
2. Is Kampo CAM? |
|---|
|
3. The Historical Background of Kampo Medicine |
|---|
|
Background Reading |
|---|
For reprints and all correspondence: Professor Katsutoshi Terasawa, Department of Japanese-Oriental (Kampo) Medicine. Faculty of Medicine,Toyama Medical and Pharmaceutical University. E-mail: terasawa@ms.toyama-mpu.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Liu, Y. Fukuwatari, K. Okumura, K. Takeda, K.-i. Ishibashi, M. Furukawa, N. Ohno, K. Mori, M. Gao, and M. Motoi Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers Evid. Based Complement. Altern. Med., June 1, 2008; 5(2): 205 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Shijie, J. Moriya, J. Yamakawa, R. Chen, T. Takahashi, H. Sumino, T. Nakahashi, K. Iwai, S. Morimoto, N. Yamaguchi, et al. Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis Evid. Based Complement. Altern. Med., February 24, 2008; (2008) nen010v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-i. Yamakawa, J. Moriya, T. Takahashi, A. Ishige, Y. Motoo, F. Yoshizaki, and T. Kanda A Kampo Medicine, Boi-ogi-to, Inhibits Obesity in Ovariectomized Rats Evid. Based Complement. Altern. Med., November 14, 2007; (2007) nem153v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Matsumoto, T. Kojima, K. Ogawa, S. Kamegai, T. Oyama, Y. Shibagaki, T. Kawasaki, H. Fujinaga, K. Takahashi, H. Hikiami, et al. A Proteomic Approach for the Diagnosis of 'Oketsu' (blood stasis), a Pathophysiologic Concept of Japanese Traditional (Kampo) Medicine Evid. Based Complement. Altern. Med., June 15, 2007; (2007) nem049v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nozaki, H. Hikiami, H. Goto, T. Nakagawa, N. Shibahara, and Y. Shimada Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 359 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Olalde Rangel, M. Magarici, F. Amendola, and O. del Castillo The Systemic Theory of Living Systems. Part IV: Systemic Medicine--The Praxis Evid. Based Complement. Altern. Med., December 1, 2005; 2(4): 429 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Terasawa Evidence-based Reconstruction of Kampo Medicine: Part II--The Concept of Sho Evid. Based Complement. Altern. Med., September 1, 2004; 1(2): 119 - 123. [Full Text] [PDF]
|
|